Hepatobiliary cancers, version 1.2017: Featured updates to the NCCN Guidelines Journal Article

   


Authors: Benson, A. B. 3rd; D'Angelica, M. I.; Abbott, D. E.; Abrams, T. A.; Alberts, S. R.; Saenz, D. A.; Are, C.; Brown, D. B.; Chang, D. T.; Covey, A. M.; Hawkins, W.; Iyer, R.; Jacob, R.; Karachristos, A.; Kelley, R. K.; Kim, R.; Palta, M.; Park, J. O.; Sahai, V.; Schefter, T.; Schmidt, C.; Sicklick, J. K.; Singh, G.; Sohal, D.; Stein, S.; Tian, G. G.; Vauthey, J. N.; Venook, A. P.; Zhu, A. X.; Hoffmann, K. G.; Darlow, S.
Article Title: Hepatobiliary cancers, version 1.2017: Featured updates to the NCCN Guidelines
Abstract: The NCCN Guidelines for Hepatobiliary Cancers provide treatment recommendations for cancers of the liver, gallbladder, and bile ducts. The NCCN Hepatobiliary Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's discussion and most recent recommendations regarding locoregional therapy for treatment of patients with hepatocellular carcinoma. © National Comprehensive Cancer Network, Inc. 2017, All rights reserved.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 15
Issue: 5
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2017-05-01
Start Page: 563
End Page: 573
Language: English
PROVIDER: scopus
PUBMED: 28476736
DOI: 10.6004/jnccn.2017.0059
PMCID: PMC5557008
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019124015&partnerID=40&md5=eb75f551daffaa6e077b6e81f010a5f7
Notes: Review -- Export Date: 2 June 2017 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Anne Covey
    167 Covey
  2. Michael D'Angelica
    780 D'Angelica
Related MSK Work